Role of Neuroreceptors in Health and Disease

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuropharmacology and Neuropathology".

Deadline for manuscript submissions: closed (23 May 2023) | Viewed by 2113

Special Issue Editor


E-Mail Website
Guest Editor
Institute for Clinical Neurobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany
Interests: glycine receptor; ion channels; inhibitory synapse; hyperekplexia; startle disease; mouse models, 3D neuronal cultures; anxiety

Special Issue Information

Dear Colleagues,

The general understanding of neuroreceptors is founded in the age-old question, “How is information processed within the brain?” The first answers to this question go back to 300 B.C. where the Pneumatic theory, a “theorie” of the functioning of the nervous system by the ancient Greeks, was postulated. Milestones in further understanding the communication of neurons were achieved much later, e.g., by the discovery of action potentials (1848, Du Bois-Reymond), the birth of the Neuron Doctrine (1888 Cajal), or the work of Sherrington (1906): “The integrative action of the nervous system”, which is postulated as the start of modern neurophysiology.

Much more has been discovered since; neuroreceptors have been well-studied and understood as being key players in the communication between and within neuronal networks. Located at the surface of neuronal or glial cells, neuroreceptors—including neurotransporters—can either excite, inhibit, or modulate their following neuron. Neuroreceptors can be activated via neurotransmitters (ligand-gated or ionotropic receptors) or via second messengers/G proteins (metabotropic receptors). Therefore, neuroreceptors shape excitatory and inhibitory synapses.

Disturbances or changes within the molecular structure of such receptors/transporters or the surrounding synapse lead to a wide spectrum of neurodegenerative or neuropsychiatric diseases (e.g., ALS, autism spectrum disorders, epilepsy, schizophrenia, startle disease). Understanding the molecular pathomechanisms of neurodegenerative or neuropsychiatric diseases has become a central topic in molecular, structural, and pharmacological neurobiology and neurophysiology. Recent research has the challenge of including and overcoming massive datasets, due to the development of more precise methods. For example, the creation and enlargement of databases, GEWAS studies, gaining precise detailed structural data, genetic applications and recent studies in pharmacology need to be analyzed. Further research is needed to provide answers to outstanding questions, and to explain insufficiently understood mechanisms. 

The aim of the current Special Issue is to present recent findings within this broad field of molecular, physiological, and pharmacological neuroreceptor/transporter research, in order to provide new mechanistic and molecular insights into the understanding of molecular pathomechanisms in neurodegenerative and neuropsychiatric diseases caused by the malfunctioning of neuroreceptors within excitatory and inhibitory synapses.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: neurodegenerative diseases, synaptic transmission, modulation of neuroreceptors or transporters, and new techniques to study neuroreceptors/transporters.

Dr. Natascha Schaefer
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuroreceptors
  • neurotransmitters, synaptic transmission
  • neurodegenerative diseases

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 505 KiB  
Review
Dopaminergic System in Promoting Recovery from General Anesthesia
by Jinxu Wang, Xiaolei Miao, Yi Sun, Sijie Li, Anshi Wu and Changwei Wei
Brain Sci. 2023, 13(4), 538; https://doi.org/10.3390/brainsci13040538 - 24 Mar 2023
Cited by 3 | Viewed by 1819
Abstract
Dopamine is an important neurotransmitter that plays a biological role by binding to dopamine receptors. The dopaminergic system regulates neural activities, such as reward and punishment, memory, motor control, emotion, and sleep–wake. Numerous studies have confirmed that the dopaminergic system has the function [...] Read more.
Dopamine is an important neurotransmitter that plays a biological role by binding to dopamine receptors. The dopaminergic system regulates neural activities, such as reward and punishment, memory, motor control, emotion, and sleep–wake. Numerous studies have confirmed that the dopaminergic system has the function of maintaining wakefulness in the body. In recent years, there has been increasing evidence that the sleep–wake cycle in the brain has similar neurobrain network mechanisms to those associated with the loss and recovery of consciousness induced by general anesthesia. With the continuous development and innovation of neurobiological techniques, the dopaminergic system has now been proved to be involved in the emergence from general anesthesia through the modulation of neuronal activity. This article is an overview of the dopaminergic system and the research progress into its role in wakefulness and general anesthesia recovery. It provides a theoretical basis for interpreting the mechanisms regulating consciousness during general anesthesia. Full article
(This article belongs to the Special Issue Role of Neuroreceptors in Health and Disease)
Show Figures

Graphical abstract

Back to TopTop